(MedPage Today) — ORLANDO — Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness in patients with type 2…
Source link : https://www.medpagetoday.com/meetingcoverage/aao/118068
Author :
Publish date : 2025-10-21 19:03:00
Copyright for syndicated content belongs to the linked Source.
